V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 180001307 | 180001725 | null | null | null | null | 2017-11-21 | null | null | null | MITOTANE | 101713080 |
| 180001470 | 180001726 | null | null | null | null | 2018-09-23 | null | null | null | NB LOW/INTERM RISK GUIDELINES CARBO/ETOP | 101042424 |
| 180001838 | 180001727 | null | null | null | null | 2018-03-20 | null | null | null | TRIAL UNSPECIFIED | 100215497 |
| 180002037 | 180001730 | null | null | null | null | 2020-08-16 | null | null | null | CABOZANTINIB | 100064034 |
| 180002678 | 180001737 | null | null | null | null | 2018-01-23 | null | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE + MITOTANE | 101393685 |
| 180002774 | 180001738 | null | null | Curative (C) | null | 2020-11-04 | null | null | null | WT SIOP 2002 01 POST OP CARBO, ETOP | 100821632 |
| 180003429 | 180001744 | null | null | null | null | 2019-08-01 | null | null | null | EVEROLIMUS | 101322928 |
| 180003583 | 180001746 | null | null | 03 | null | 2020-07-20 | null | null | null | CAPECITABINE | 100159763 |
| 180003853 | 180001749 | null | null | Palliative (P) | null | 2020-12-02 | null | null | null | ATEZOLIZUMAB + CARBOPLATIN + ETOPOSIDE | 101585930 |
| 180004004 | 180001751 | null | null | null | null | 2019-03-27 | null | null | null | AZACITIDINE | 101820735 |
| 180004053 | 180001752 | null | null | null | null | 2017-01-18 | null | null | null | NOT MATCHED | 101226306 |
| 180004074 | 180001753 | null | null | null | null | 2019-04-13 | null | null | null | PALBOCICLIB | 100572580 |
| 180004762 | 180001758 | null | null | null | null | 2018-02-10 | null | null | null | CARBOPLATIN + GEMCITABINE | 101819412 |
| 180004820 | 180001760 | null | null | null | null | 2020-01-25 | null | null | null | NB HRNBL-1 COJEC IND COURSE A | 100943504 |
| 180005219 | 180001763 | null | null | null | null | 2018-12-14 | null | null | null | CARBOPLATIN + PEMETREXED | 101433881 |
| 180006406 | 180001774 | null | null | null | null | 2018-12-23 | null | null | null | NB HRNBL-1 COJEC IND COURSE A | 100550558 |
| 180006690 | 180001776 | null | null | null | null | 2018-12-24 | null | null | null | CISPLATIN + RT | 100488838 |
| 180006891 | 180001779 | null | null | Palliative (P) | null | 2019-07-12 | null | null | null | NB HRNBL-1 COJEC IND COURSE A | 100509469 |
| 180007170 | 180001782 | null | null | Palliative (P) | null | 2021-08-19 | null | null | null | NB HRNBL-1 COJEC IND COURSE A | 101811280 |
| 180007207 | 180001784 | null | null | Palliative (P) | null | 2019-11-13 | null | null | null | NB HRNBL-1 COJEC IND COURSE B | 100314802 |
| 180007386 | 180001786 | null | null | Palliative (P) | null | 2017-07-03 | null | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE + MITOTANE | 100841945 |
| 180007867 | 180001790 | null | null | null | null | 2019-09-06 | null | null | null | NB LOW/INTERM RISK GUIDELINES CARBO/ETOP | 101807444 |
| 180007900 | 180001792 | null | null | null | null | 2018-12-24 | null | null | null | RITUXIMAB | 101694687 |
| 180008511 | 180001795 | null | null | null | null | null | null | null | null | BACILLUS CALMETTE-GUERIN | 101861863 |
| 180009315 | 180001799 | null | null | null | null | 2016-05-07 | null | null | null | NOT MATCHED | 100769911 |
| 180009345 | 180001801 | null | null | null | null | 2019-12-08 | null | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE | 101622578 |
| 180009751 | 180001808 | null | null | null | null | 2019-11-16 | null | null | null | NB HRNBL-1 COJEC IND COURSE A | 100908297 |
| 180009968 | 180001810 | null | null | Curative (C) | null | 2019-08-16 | null | null | null | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | 100932245 |
| 180010820 | 180001818 | null | null | Palliative (P) | null | 2018-08-25 | null | null | null | NB HRNBL-1 COJEC IND COURSE A | 101631076 |
| 180011261 | 180001823 | null | null | null | null | 2019-09-22 | null | null | null | NB HRNBL-1 COJEC IND COURSE A | 101175934 |
| 180011491 | 180001826 | null | null | null | null | 2022-03-21 | null | null | null | NB HRNBL-1 COJEC IND COURSE A | 101266331 |
| 180011645 | 180001828 | null | null | null | null | 2016-04-11 | null | null | null | IMATINIB | 101622307 |
| 180011689 | 180001829 | null | null | null | null | 2019-03-03 | null | null | null | SORAFENIB | 101069206 |
| 180012294 | 180001835 | null | null | null | null | 2017-12-18 | null | null | null | NOT MATCHED | 100332877 |
| 180012414 | 180001838 | null | null | null | null | 2018-06-28 | null | null | null | CNS GCT II GERMINOMA - CARBO ETOP | 100006652 |
| 180012443 | 180001840 | null | null | Curative (C) | null | 2020-02-07 | null | null | null | CHOP R | 101582699 |
| 180012753 | 180001849 | null | null | null | null | 2017-01-26 | null | null | null | PEMBROLIZUMAB | 101593174 |
| 180012944 | 180001853 | null | null | null | null | 2016-12-07 | null | null | null | LENVATINIB | 100643211 |
| 180001274 | 180001861 | null | null | null | null | 2022-03-16 | null | null | null | SORAFENIB | 100165326 |
| 180008149 | 180001862 | null | null | null | null | 2016-08-18 | null | null | null | ABVD | 100165462 |
| 180000070 | 180001872 | null | null | null | null | 2018-10-29 | Paclitaxel (2 or 3 weekly) | null | null | DINUTUXIMAB BETA | 100669538 |
| 180000113 | 180001875 | 1.8 | null | null | null | 2019-09-09 | BUSULFAN + MELPHALAN | null | null | CARBOPLATIN + PACLITAXEL | 101085442 |
| 180000173 | 180001878 | null | null | null | 2020-01-09 | 2020-01-14 | CABOZANTINIB | null | null | CAPECITABINE + GEMCITABINE | 100225817 |
| 180000209 | 180001880 | null | null | null | null | 2019-06-08 | CNS GCT II Non Germin - Std PEI | null | null | NOT MATCHED | 100003728 |
| 180000382 | 180001893 | null | null | null | null | 2022-05-14 | IBRUTINIB | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101212008 |
| 180000391 | 180001894 | null | null | null | 2017-08-19 | 2017-08-25 | NB BEACON Temozolomide Irinotecan | null | null | DINUTUXIMAB BETA | 101241086 |
| 180000455 | 180001903 | null | null | null | null | 2017-07-09 | null | null | null | FLUOROURACIL + IRINOTECAN | 101363256 |
| 180000506 | 180001905 | null | null | null | null | 2016-08-24 | LENVATINIB | null | null | NB HRNBL-1 ISOTRETINOIN | 100995185 |
| 180000525 | 180001906 | null | null | null | null | 2022-01-21 | LENVATINIB | 02 | null | TRIAL UNSPECIFIED | 100020014 |
| 180000670 | 180001911 | null | null | null | 2019-08-29 | 2020-02-11 | Irinotecan + Modified De Gramont | null | null | CAPECITABINE | 101531313 |